Advaxis Inc
BioTech/Drugs - Princeton, NJ, US
Advaxis Inc Details
Advaxis (NASDAQ: ADXS) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. The Advaxis technology, using bioengineered live attenuated bacteria, Listeria monocytogenes (Lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.
Website:
advaxis.com
Employees:
100 - 249
HQ:
609-452-9813
Location:
Princeton, NJ, US
Revenue:
10 - 20 Million
Advaxis Inc Technologies
Email Providers
Outlook
Domain Name Services
Route 53
CMS
Drupal
SSL Certificates
Media Temple SSL
Hosting
Amazon AWS
Search Marketing
Adobe Marketing Cloud